Dikla Czaczkes Akselbrad stands prominently in the world of life sciences and infection prevention, serving as the CEO of PolyPid. She assumed the reins as executive vice president and chief financial officer in 2017, before navigating the company through its Nasdaq IPO in June 2020. With a repertoire spanning over two decades, Akselbrad has leavened…